[go: up one dir, main page]

NO996580L - 5- (2-Ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine maleate - Google Patents

5- (2-Ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine maleate

Info

Publication number
NO996580L
NO996580L NO996580A NO996580A NO996580L NO 996580 L NO996580 L NO 996580L NO 996580 A NO996580 A NO 996580A NO 996580 A NO996580 A NO 996580A NO 996580 L NO996580 L NO 996580L
Authority
NO
Norway
Prior art keywords
tetrazol
ethyl
methyl
tetrahydropyridine
maleate
Prior art date
Application number
NO996580A
Other languages
Norwegian (no)
Other versions
NO996580D0 (en
Inventor
Michael Bech Sommer
Ole Nielsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO996580D0 publication Critical patent/NO996580D0/en
Publication of NO996580L publication Critical patent/NO996580L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører et maleatsyre- addisjonssalt av 5-(2-etyl-2tf-tetrazol-5-yl)-1-metyl- 1,2,3,6-tetrahydropyridin, farmasøytiske sammensetninger inneholdende syreaddisjonssaltet og anvendelsen derav for behandlingen av forstyrrelser forårsaket av en svikt i cC.V- eller muskarinsystemet.The present invention relates to a malate acid addition salt of 5- (2-ethyl-2-t-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine, pharmaceutical compositions containing the acid addition salt and its use in the treatment of disorders. caused by a failure of the cC.V or muscarinic system.

NO996580A 1997-07-01 1999-12-30 5- (2-Ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine maleate NO996580L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01
PCT/DK1998/000294 WO1999001448A1 (en) 1997-07-01 1998-07-01 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate

Publications (2)

Publication Number Publication Date
NO996580D0 NO996580D0 (en) 1999-12-30
NO996580L true NO996580L (en) 1999-12-30

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996580A NO996580L (en) 1997-07-01 1999-12-30 5- (2-Ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine maleate

Country Status (25)

Country Link
EP (1) EP0994869A1 (en)
JP (1) JP2002507215A (en)
KR (1) KR20010014297A (en)
CN (1) CN1261361A (en)
AR (1) AR013096A1 (en)
AU (1) AU735751B2 (en)
BG (1) BG103933A (en)
BR (1) BR9810331A (en)
CA (1) CA2293324A1 (en)
CO (1) CO4940483A1 (en)
EA (1) EA200000081A1 (en)
HU (1) HUP0002876A2 (en)
IL (1) IL133093A0 (en)
IS (1) IS5278A (en)
JO (1) JO2031B1 (en)
MA (1) MA25138A1 (en)
NO (1) NO996580L (en)
PE (1) PE116099A1 (en)
PL (1) PL337184A1 (en)
SK (1) SK187399A3 (en)
TN (1) TNSN98120A1 (en)
TR (1) TR199903283T2 (en)
UY (2) UY25069A1 (en)
WO (1) WO1999001448A1 (en)
ZA (1) ZA985498B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
PL326490A1 (en) * 1995-11-06 1998-09-28 Lundbeck & Co As H Treatment of traumatic brain injuries

Also Published As

Publication number Publication date
MA25138A1 (en) 2001-04-02
JO2031B1 (en) 1999-05-15
EA200000081A1 (en) 2000-08-28
CN1261361A (en) 2000-07-26
TNSN98120A1 (en) 2005-03-15
TR199903283T2 (en) 2000-06-21
IS5278A (en) 1999-11-30
SK187399A3 (en) 2000-06-12
AU8102098A (en) 1999-01-25
PL337184A1 (en) 2000-08-14
CO4940483A1 (en) 2000-07-24
EP0994869A1 (en) 2000-04-26
NO996580D0 (en) 1999-12-30
ZA985498B (en) 1999-01-20
JP2002507215A (en) 2002-03-05
KR20010014297A (en) 2001-02-26
WO1999001448A1 (en) 1999-01-14
BR9810331A (en) 2000-09-05
HUP0002876A2 (en) 2001-06-28
UY25177A1 (en) 2000-12-29
IL133093A0 (en) 2001-03-19
AR013096A1 (en) 2000-12-13
BG103933A (en) 2000-07-31
UY25069A1 (en) 1998-12-21
AU735751B2 (en) 2001-07-12
CA2293324A1 (en) 1999-01-14
PE116099A1 (en) 1999-11-23

Similar Documents

Publication Publication Date Title
DE69427704D1 (en) NEW (R) -5-CARBAMOYL-8-FLUOR-3-N, N-DISUBSTITUTED-AMINO-3,4-DIHYDRO-2H-1-BENZOPYRANE
EP0668863A1 (en) CHINUCLIDINE DERIVATIVE AS SUBSTANCE P ANTAGONIST.
BG103297A (en) Aralkyl and aralkyliden heterocyclic lactams and imides
MY128654A (en) Liquid pharmaceutical composition containing an erythropoietin derivative
NO985977L (en) Spiro-piperidine derivatives and their use as therapeutic agents
MX9701679A (en) Piperidine derivatives as neurokinin antagonists.
EP0896533A4 (en) Pentafluorobenzenesulfonamides and analogs
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
TR200101962T2 (en) 4- (aminomethyl) -piperidine benzamides to treat digestive system disorders
ATE439346T1 (en) COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES
TNSN96174A1 (en) AZETIDINES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
EA199700032A1 (en) DISINFECTING COMPOSITION "VELTOLEN"
PT615751E (en) UTILIZATION OF TAQUININE ANTAGONISTS IN EMESE TREATMENT
AU4310097A (en) Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
BR9503572A (en) Compound pharmaceutical composition and method of treatment or prevention of a disease
FI943499A0 (en) Acid surrogate containing tetrahedro-1H-benzazepinones
DE69925270D1 (en) MEANS TO TREAT JUCKREIZ, CONTAINING PGD2 ANTAGONISTS
BR9811821A (en) 2-acylaminopropanamines as tachykinin receptor antagonists
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine
BG103306A (en) Liquid allendronate compositions
DK0552765T3 (en) benzimidazoles, pharmaceutical compositions containing them and processes for their preparation
WO1996031208A3 (en) Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
ATE187956T1 (en) SUBSTITUTED CONDENSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS
NO996580L (en) 5- (2-Ethyl-2H-tetrazol-5-yl) -1-methyl-1,2,3,6-tetrahydropyridine maleate
FI942468A0 (en) Chemical compounds, their preparation and use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application